| | | | | |
FATE Fate Therapeutics, Inc. | €2,2697 | +3,52% | €271,54M | €973,62K | |
| €35,7846 | -0,90% | €271,47M | €10,62K | |
MLP Maui Land & Pineapple Co. | €13,6098 | -1,37% | €271,37M | €27,52K | |
NMRA Neumora Therapeutics, Inc. Common Stock | €1,4089 | +0,31% | €271,37M | €547,50K | |
GALT Galectin Therapeutics Inc. | €3,1434 | +4,26% | €271,22M | €280,22K | |
NREF NexPoint Real Estate Finance, Inc. | €15,0144 | +2,04% | €271,20M | €68,30K | |
POLE Andretti Acquisition Corp. II Class A Ordinary Shares | €9,2588 | -0,19% | €270,95M | €28,26 | |
| €2,9121 | +6,25% | €270,73M | €520,35K | |
EFR Eaton Vance Senior Floating-Rate Fund | €9,1303 | +0,09% | €270,57M | €176,77K | |
SMTI Sanara MedTech Inc. Common Stock | €29,3608 | +0,32% | €270,30M | €280,40K | |
TVA Texas Ventures Acquisition III Corp Class A Ordinary Share | €9,0275 | +0,10% | €270,05M | €23,96K | |
ALTO Alto Ingredients, Inc. Common Stock | €3,5973 | -0,94% | €269,73M | €808,85K | |
RNGT Range Capital Acquisition Corp II Class A Ordinary Shares | €8,6849 | -0,10% | €269,38M | €2,57K | |
AFB Alliance National Municipal Income Fund, Inc. | €9,3958 | -0,09% | €269,34M | €82,40K | |
SSP The E.W. Scripps Company | €2,9549 | +4,55% | €269,06M | €355,73K | |
